{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:48:03Z","timestamp":1790088483917,"version":"4.0.1"},"reference-count":111,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics and Practice"],"abstract":"<jats:p>Introduction: Breast cancer affects almost 1.5 million women worldwide below the age of 45 years each year. Many of these women will be advised to undergo adjuvant chemotherapy to minimize the risk of death or recurrence of the tumor. For these patients, chemotherapy is a known cause of infertility, as it can damage primordial follicles, which can lead to early menopause or premature ovarian insufficiency. This systematic review aims to synthesize the current evidence of the most suitable treatments for fertility preservation. Methodology: This review was performed following the PRISMA guidelines. The authors conducted an extensive search from the last 15 years. Relevant studies were pursued in PubMed, Embase, and the Cochrane Library up until 31 July 2023. A total of seven eligible studies were identified. Results: From the reviewed literature, ovarian suppression with gonadotropin-releasing hormone agonists showed promising results in preserving fertility for breast cancer patients undergoing chemotherapy. Additionally, oocyte and embryo cryopreservation demonstrated successful outcomes, with embryo cryopreservation being the most effective option. Notably, the slow-freezing and vitrification methods were both effective in preserving embryos, with vitrification showing superior results in clinical-assisted reproductive technologies. Ovarian tissue cryopreservation emerged as a viable option for prepubertal girls and those unable to undergo conventional ovarian stimulation. The potential of in vitro maturation (IVM) as an alternative method presents a promising avenue for future fertility preservation research. Discussion: The most suitable treatments for fertility preservation in young patients is the temporary suppression with luteinizing hormone-releasing analogs, while the patient undergoes chemotherapy and cryopreservation. For cryopreservation, the physicians might deem it necessary to either cryopreserve ovarian tissue taken from the patient before any treatment or cryopreserve embryos\/oocytes. Cryopreservation of oocytes and\/or embryos is the most effective solution for fertility preservation in women of reproductive age, who have a sufficient ovarian reserve and are diagnosed with breast cancer, regardless of the histological type of the tumor. Because approximately 50% of young breast cancer patients are interested in becoming pregnant right after completion of therapy, the evolution and development of fertility preservation techniques promise to be very exciting.<\/jats:p>","DOI":"10.3390\/clinpract13060127","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T08:44:27Z","timestamp":1699865067000},"page":"1413-1426","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Breast Cancer and Fertility Preservation in Young Female Patients: A Systematic Review of the Literature"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3667-4520","authenticated-orcid":false,"given":"Ioannis","family":"Boutas","sequence":"first","affiliation":[{"name":"Breast Unit, Rea Maternity Hospital, P. Faliro, 17564 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adamantia","family":"Kontogeorgi","sequence":"additional","affiliation":[{"name":"Third Department of Obstetrics and Gynecology, Attikon University Hospital, National and Kapodistrian University of Athens, Rimini 1, 12462 Chaidari, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9502-7916","authenticated-orcid":false,"given":"Nektarios","family":"Koufopoulos","sequence":"additional","affiliation":[{"name":"Second Pathology Department, Attikon University Hospital, National and Kapodistrian University of Athens, Rimini 1, 12462 Chaidari, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionysios T.","family":"Dimas","sequence":"additional","affiliation":[{"name":"Breast Unit, Athens Medical Center, Psychiko Clinic, 11525 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyparissia","family":"Sitara","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, \u201cElpis\u201d General Hospital, 11522 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia N.","family":"Kalantaridou","sequence":"additional","affiliation":[{"name":"Third Department of Obstetrics and Gynecology, Attikon University Hospital, National and Kapodistrian University of Athens, Rimini 1, 12462 Chaidari, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine","family":"Dimitrakakis","sequence":"additional","affiliation":[{"name":"First Department of Obstetrics and Gynecology, Alexandra University Hospital, National and Kapodistrian University of Athens, Lourou 4-2, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,13]]},"reference":[{"key":"ref_1","unstructured":"(2023, May 07). National Cancer Institute\u2014Surveillance, Epidemiology and End Results Program, Available online: http:\/\/seer.cancer.gov\/statfacts\/html\/breast.html."},{"key":"ref_2","unstructured":"Stewart, B.W., and Wild, C.P. (2014). World Cancer Report 2014, WHO Press."},{"key":"ref_3","unstructured":"WHO (2023, May 07). Breast Cancer. Available online: https:\/\/who.int\/news-room\/fact-sheets\/detail\/breast-cancer."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s13058-014-0427-5","article-title":"Biology of breast cancer in young women","volume":"16","author":"Azim","year":"2014","journal-title":"Breast Cancer Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/bjc.2016.359","article-title":"The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients","volume":"115","author":"Lambertini","year":"2016","journal-title":"Br. J. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.7314\/APJCP.2014.15.8.3353","article-title":"Breast cancer: Major risk factors and recent developments in treatment","volume":"15","author":"Majeed","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/jnci\/djr541","article-title":"Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: A systematic review","volume":"104","author":"Ganz","year":"2012","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jamaoncol.2015.2112","article-title":"Breast cancer in young women: Rare disease or public health problem?","volume":"1","author":"Rosenberg","year":"2015","journal-title":"JAMA Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3322\/caac.21320","article-title":"Breast cancer statistics, 2015: Convergence of incidence rates between black and white women","volume":"66","author":"DeSantis","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1200\/JCO.2013.49.2678","article-title":"Fertility preservation for patients with cancer: American society of clinical oncology clinical practice guideline update","volume":"31","author":"Loren","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"vi160","DOI":"10.1093\/annonc\/mdt199","article-title":"Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Peccatori","year":"2013","journal-title":"Ann. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.breast.2015.12.010","article-title":"Second international consensus guidelines for breast cancer in young women (BCY2)","volume":"26","author":"Pagani","year":"2016","journal-title":"Breast"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1196\/annals.1434.011","article-title":"Ovarian reserve","volume":"1127","author":"Coccia","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_14","first-page":"103","article-title":"Viable options for fertility preservation in breast cancer patients: A focus on latin america","volume":"69","author":"Lambertini","year":"2017","journal-title":"Rev. Investig. Clin. Organo Hosp. Enfermedades Nutr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/cncr.26459","article-title":"Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer","volume":"118","author":"Letourneau","year":"2012","journal-title":"Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/ijc.26045","article-title":"Pregnancy after adolescent and adult cancer: A population-based matched cohort study","volume":"129","author":"Stensheim","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2147\/DHPS.S24106","article-title":"Efficacy and safety of gonadotropin-releasing hormone agonists used in the treatment of prostate cancer","volume":"3","author":"Choi","year":"2011","journal-title":"Drug Health Patient Saf."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1001\/jama.1988.03720140043031","article-title":"The Relationship of gonadal activity and chemotherapy-induced gonadal damage","volume":"259","author":"Rivkees","year":"1988","journal-title":"JAMA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s42000-023-00443-9","article-title":"Fertility status in childhood cancer survivors of hematological malignancies: A systematic review","volume":"22","author":"Karalexi","year":"2023","journal-title":"Hormones"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra043475","article-title":"Potential options for preservation of fertility in women","volume":"353","author":"Lobo","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1634\/theoncologist.12-9-1044","article-title":"How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries","volume":"12","author":"Blumenfeld","year":"2007","journal-title":"Oncologist"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1200\/JCO.2012.41.8467","article-title":"Gonadotropin-Releasing Hormone agonist for preservation of ovarian function during (Neo)adjuvant chemotherapy for breast cancer","volume":"30","author":"Blumenfeld","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1056\/NEJM199101103240205","article-title":"Gonadotropin-releasing hormone and its analogues","volume":"324","author":"Desforges","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"ref_24","first-page":"905","article-title":"Effect of Zoladex administered before chemotherapy on menstruation of patients with breast cancer","volume":"35","author":"Li","year":"2008","journal-title":"Chin. J. Clin. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.fertnstert.2007.12.044","article-title":"Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: Prospective randomized study","volume":"91","author":"Badawy","year":"2009","journal-title":"Fertil. Steril."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s10549-009-0313-5","article-title":"Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: Results from a randomized trial","volume":"117","author":"Sverrisdottir","year":"2009","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1200\/JCO.2010.32.5704","article-title":"Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: The GBG 37 ZORO study","volume":"29","author":"Gerber","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_28","first-page":"15","article-title":"Effect of Zoladex administered before chemotherapy on menstruation of patients with breast cancer","volume":"19","author":"Sun","year":"2011","journal-title":"China Disabil. Med."},{"key":"ref_29","first-page":"269","article-title":"Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: A randomized trial","volume":"306","author":"Boni","year":"2011","journal-title":"JAMA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1200\/JCO.2011.34.6890","article-title":"Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer","volume":"30","author":"Munster","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/AOG.0b013e31827374e2","article-title":"Gonadatrophin suppression to prevent chemotherapy-induced ovarian damage: A randomized controlled trial","volume":"121","author":"Elgindy","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s12032-013-0667-8","article-title":"Effect of leuprolide acetate on ovarian function after cyclophosphamide-doxorubicin-based chemotherapy in premenopausal patients with breast cancer: Results from a phase II randomized trial","volume":"30","author":"Song","year":"2013","journal-title":"Med. Oncol."},{"key":"ref_33","first-page":"16","article-title":"Protective effect of GnRHa on chemo-therapy induced ovarian damage in breast cancer patients","volume":"53","author":"Jiang","year":"2013","journal-title":"Shandong Med. J."},{"key":"ref_34","first-page":"59","article-title":"Evaluation of the effect of GnRH agonist on menstrual reverse in breast cancer cases treated with cyclophosphamide","volume":"35","author":"Vafaeenasab","year":"2014","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1056\/NEJMoa1413204","article-title":"Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy","volume":"372","author":"Moore","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/annonc\/mdx184","article-title":"GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: The Anglo Celtic Group OPTION trial","volume":"28","author":"Leonard","year":"2017","journal-title":"Ann. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s10549-018-4660-y","article-title":"Sequential versus simultaneous use of chemotherapy and gonadotropin-releasing hormone agonist (GnRHa) among estrogen receptor (ER)-positive premenopausal breast cancer patients: Effects on ovarian function, disease-free survival, and overall survival","volume":"168","author":"Zhang","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3389\/fonc.2020.00863","article-title":"Prediction of Successful Ovarian Protection Using Gonadotropin-Releasing Hormone Agonists During Chemotherapy in Young Estrogen Receptor-Negative Breast Cancer Patients","volume":"10","author":"Lee","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1001\/jamaoncol.2021.6214","article-title":"Effects of Gonadotropin-Releasing Hormone Analogs on Ovarian Function Against Chemotherapy-Induced Gonadotoxic Effects in Premenopausal Women With Breast Cancer in China","volume":"8","author":"Zong","year":"2022","journal-title":"JAMA Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"690320","DOI":"10.3389\/fonc.2021.690320","article-title":"The PREgnancy and FERtility (PREFER) Study Investigating the Need for Ovarian Function and\/or Fertility Preservation Strategies in Premenopausal Women With Early Breast Cancer","volume":"11","author":"Blondeaux","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Blumenfeld, Z. (2019). Fertility Preservation Using GnRH Agonists: Rationale, Possible Mechanisms, and Explanation of Controversy. Clin. Med. Insights Reprod. Health, 13.","DOI":"10.1177\/1179558119870163"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.clbc.2023.01.006","article-title":"Approaches to Fertility Preservation for Young Women With Breast Cancer","volume":"23","author":"Razeti","year":"2023","journal-title":"Clin. Breast Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Practice Committee of the American Society for Reproductive Medicine (2019). Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: A committee opinion. Fertil. Steril., 112, 1022\u20131033.","DOI":"10.1016\/j.fertnstert.2019.09.013"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1200\/JCO.2005.05.037","article-title":"Fertility preservation in breast cancer patients: A prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation","volume":"23","author":"Oktay","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3109\/09513590.2013.819083","article-title":"Is letrozole needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer?","volume":"29","author":"Revelli","year":"2013","journal-title":"Gynecol. Endocrinol."},{"key":"ref_46","first-page":"CD010240","article-title":"Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction","volume":"11","author":"Dahhan","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/humrep\/deac145","article-title":"Fertility preservation for women with breast cancer: A multicentre randomized controlled trial on various ovarian stimulation protocols","volume":"37","author":"Balkenende","year":"2022","journal-title":"Hum. Reprod."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10815-020-02030-y","article-title":"Effects of letrozole or tamoxifen coadministered with a standard stimulation protocol on fertility preservation among breast cancer patients","volume":"38","author":"Shulman","year":"2021","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Sonigo, C., Sermondade, N., Calvo, J., Benard, J., Sifer, C., and Grynberg, M. (2019). Impact of letrozole supplementation during ovarian stimulation for fertility preservation in breast cancer patients. Eur. J. Obstet. Gynecol. Reprod. Biol. X, 4.","DOI":"10.1016\/j.eurox.2019.100049"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1634\/theoncologist.11-5-422","article-title":"Fertility preservation in young women undergoing breast cancer therapy","volume":"11","author":"Sonmezer","year":"2006","journal-title":"Oncologist"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1210\/jc.2006-0962","article-title":"Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy","volume":"91","author":"Oktay","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.rbmo.2010.03.004","article-title":"GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor\/FSH stimulation","volume":"20","author":"Oktay","year":"2010","journal-title":"Reprod. Biomed. Online"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/humrep\/deg045","article-title":"Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen","volume":"18","author":"Oktay","year":"2003","journal-title":"Hum. Reprod."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.fertnstert.2012.09.022","article-title":"Ovarian stimulation and fertility preservation with the use of aromatase inhibitors in women with breast cancer","volume":"98","author":"Reddy","year":"2012","journal-title":"Fertil. Steril."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1200\/JCO.2005.04.011","article-title":"Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation","volume":"23","author":"Oktay","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.rbmo.2012.02.020","article-title":"The effects of letrozole on ovarian stimulation for fertility preservation in cancer-affected women","volume":"24","author":"Corchado","year":"2012","journal-title":"Reprod. Biomed. Online"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Lalami, I., Labrosse, J., Cedrin-Durnerin, I., Comtet, M., Vinolas, C., Krief, F., Sifer, C., Peigne, M., and Grynberg, M. (2022). Is letrozole during ovarian stimulation useful in breast cancer patients undergoing fertility preservation to reduce early luteal progesterone levels following GnRH-agonist trigger?. Reprod. Biol. Endocrinol., 20.","DOI":"10.1186\/s12958-022-00958-7"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.fertnstert.2020.07.008","article-title":"Ovarian follicular waves during the menstrual cycle: Physiologic insights into novel approaches for ovarian stimulation","volume":"114","author":"Baerwald","year":"2020","journal-title":"Fertil. Steril."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2174\/1389201018666170808122531","article-title":"Random start ovarian stimulation for oocyte or embryo cryopreservation in women desiring fertility preservation prior to gonadotoxic cancer therapy","volume":"18","author":"Danis","year":"2017","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.rbmo.2014.08.009","article-title":"Double stimulations during the follicular and luteal phases of poor responders in IVF\/ICSI programmes (Shanghai protocol)","volume":"29","author":"Kuang","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.fertnstert.2016.03.002","article-title":"Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: New insight in ovarian reserve exploitation","volume":"105","author":"Ubaldi","year":"2016","journal-title":"Fertil. Steril."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10815-019-01638-z","article-title":"What is the true place of a double stimulation and double oocyte retrieval in the same cycle for patients diagnosed with poor ovarian reserve? A systematic review including a meta-analytical approach","volume":"37","author":"Sfakianoudis","year":"2020","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"E1003","DOI":"10.1503\/cmaj.200245","article-title":"Update on fertility preservation for younger women with breast cancer","volume":"192","author":"Warner","year":"2020","journal-title":"Can. Med. Assoc. J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.annonc.2020.09.006","article-title":"Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines","volume":"31","author":"Lambertini","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"ESHRE Guideline Group on female fertility preservation, Anderson, R.A., Amant, F., and Braat, D. (2020). ESHRE guideline: Female fertility preservation. Hum. Reprod. Open, 4, hoaa052.","DOI":"10.1093\/hropen\/hoaa052"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1093\/humrep\/dey321","article-title":"Elective and onco-fertility preservation: Factors related to IVF outcomes","volume":"33","author":"Cobo","year":"2018","journal-title":"Hum. Reprod."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0015-0282(16)53644-9","article-title":"Transient cooling to room temperature can cause irreversible disruption of the meiotic spindle in the human oocyte","volume":"54","author":"Pickering","year":"1990","journal-title":"Fertil. Steril."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/oxfordjournals.humrep.a137654","article-title":"Effects of 1,2-propanediol on the cytoskeletal organization of the mouse oocyte","volume":"7","author":"Joly","year":"1992","journal-title":"Hum. Reprod."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1028-4559(09)60030-9","article-title":"Slow freezing or vitrification of oocytes: Their effects on survival and meiotic spindles, and the time schedule for clinical practice","volume":"48","author":"Chen","year":"2009","journal-title":"Taiwan J. Obstet. Gynecol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/MED.0000000000000289","article-title":"Evolution of human oocyte cryopreservation: Slow freezing versus vitrification","volume":"23","author":"Patrizio","year":"2016","journal-title":"Curr. Opin. Endocrinol. Diabetes"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10815-014-0180-9","article-title":"Oocyte vitrification: Advances, progress and future goals","volume":"31","author":"Chian","year":"2014","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_72","first-page":"139","article-title":"Oocyte, embryo and blastocyst cryopreservation in ART: Systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance","volume":"23","author":"Rienzi","year":"2017","journal-title":"Hum. Reprod. Updat."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"103201","DOI":"10.1016\/j.critrevonc.2020.103201","article-title":"Preimplantation genetic testing for carriers of BRCA1\/2 pathogenic variants","volume":"157","author":"Peccatori","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1200\/JCO.2014.59.3723","article-title":"Fertility preservation success subsequent to concurrent aromatase inhibitor treatment and ovarian stimulation in women with breast cancer","volume":"33","author":"Oktay","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/GCO.0b013e32834874e2","article-title":"Current status of human oocyte and embryo cryopreservation","volume":"23","author":"Herrero","year":"2011","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/bmj.39035.667176.55","article-title":"Pregnancy after breast cancer: Population based study","volume":"334","author":"Ives","year":"2007","journal-title":"BMJ"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1586\/era.10.208","article-title":"Motherhood after breast cancer: Searching for la dolce vita","volume":"11","author":"Azim","year":"2011","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.breast.2021.07.021","article-title":"Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy","volume":"59","author":"Partridge","year":"2021","journal-title":"Breast"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1634\/theoncologist.2011-0121","article-title":"Use of tamoxifen before and during pregnancy","volume":"16","author":"Braems","year":"2011","journal-title":"Oncologist"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-94-007-2492-1_6","article-title":"The unique reproductive concerns of young women with breast cancer","volume":"732","author":"Ruddy","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/rmb2.12054","article-title":"Effects of fertility preservation in patients with breast cancer: A retrospective two-centers study","volume":"16","author":"Hashimoto","year":"2017","journal-title":"Reprod. Med. Biol."},{"key":"ref_82","first-page":"2051","article-title":"Fertility preservation in female oncology patients: The influence of the type of cancer on ovarian stimulation response","volume":"33","author":"Alvarez","year":"2018","journal-title":"Hum. Reprod."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology (2013). Mature oocyte cryopreservation: A guideline. Fertil. Steril., 99, 37\u201343.","DOI":"10.1016\/j.fertnstert.2012.09.028"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3389\/fendo.2018.00347","article-title":"Cryopreservation of Ovarian Tissue: Opportunities Beyond Fertility Preservation and a Positive View Into the Future","volume":"9","author":"Kristensen","year":"2018","journal-title":"Front. Endocrinol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.fertnstert.2021.03.008","article-title":"Transplantation of cryopreserved ovarian tissue in a series of 285 women: A review of five leading European centers","volume":"115","author":"Dolmans","year":"2021","journal-title":"Fertil. Steril."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10549-017-4288-3","article-title":"Fertility preservation with ovarian stimulation and time to treatment in women with stage II\u2013III breast cancer receiving neoadjuvant therapy","volume":"165","author":"Chien","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jogoh.2018.05.008","article-title":"Breast cancer and ovarian tissue cryopreservation: Review of the literature","volume":"47","author":"Fleury","year":"2018","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13048-021-00929-3","article-title":"Ovarian tissue cryopreservation in a patient with breast cancer during pregnancy: A case report","volume":"14","author":"Cheng","year":"2021","journal-title":"J. Ovarian Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.2217\/fon.12.152","article-title":"Cryopreservation of ovarian tissue in breast cancer patients: 10 years of experience","volume":"8","author":"Fabbri","year":"2012","journal-title":"Futur. Oncol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10815-016-0843-9","article-title":"86 successful births and 9 ongoing pregnancies worldwide in women transplanted with frozen-thawed ovarian tissue: Focus on birth and perinatal outcome in 40 of these children","volume":"34","author":"Jensen","year":"2017","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/humrep\/dew165","article-title":"Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: Tissue activity, pregnancy and delivery rates","volume":"31","author":"Liebenthron","year":"2016","journal-title":"Hum. Reprod."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.fertnstert.2010.07.1080","article-title":"Autotransplantation of cryopreserved ovarian tissue in 12 women with chemotherapy-induced premature ovarian failure: The Danish experience","volume":"95","author":"Schmidt","year":"2011","journal-title":"Fertil. Steril."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1093\/humrep\/den244","article-title":"Two successful pregnancies following autotransplantation of frozen\/thawed ovarian tissue","volume":"23","author":"Andersen","year":"2008","journal-title":"Hum. Reprod."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2217\/fon.13.234","article-title":"Autotransplantation of cryopreserved ovarian tissue in oncological patients: Recovery of ovarian function","volume":"10","author":"Fabbri","year":"2014","journal-title":"Future Oncol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/humrep\/deu158","article-title":"Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility: A 12-year retrospective analysis","volume":"29","author":"Imbert","year":"2014","journal-title":"Hum. Reprod."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"268.e11","DOI":"10.1016\/j.fertnstert.2009.09.046","article-title":"Twins born after transplantation of ovarian cortical tissue and oocyte vitrification","volume":"93","author":"Crespo","year":"2010","journal-title":"Fertil. Steril."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s10815-013-0026-x","article-title":"Legal termination of a pregnancy resulting from transplanted cryopreserved ovarian tissue due to cancer recurrence","volume":"30","author":"Ernst","year":"2013","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.rbmo.2010.10.015","article-title":"Cryopreservation of ovarian tissue for a decade in Denmark: A view of the technique","volume":"22","author":"Rosendahl","year":"2011","journal-title":"Reprod. Biomed. Online"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/1414-431x20175612","article-title":"Estrogen and progesterone promote breast cancer cell proliferation by inducing cyclin G1 expression","volume":"51","author":"Tian","year":"2018","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_100","first-page":"438","article-title":"In-Vitro Fertilization Impact on the Risk of Breast Cancer: A Review Article","volume":"50","author":"Farhud","year":"2021","journal-title":"Iran. J. Public. Health"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s10815-017-1005-4","article-title":"Vitrification of human immature oocytes before and after in vitro maturation: A review","volume":"34","author":"Khalili","year":"2017","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bpobgyn.2009.11.007","article-title":"Cryopreservation of oocytes and embryos for fertility preservation for female cancer patients","volume":"24","author":"Ata","year":"2010","journal-title":"Best. Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.rbmo.2010.05.003","article-title":"Fertility preservation for breast-cancer patients using IVM followed by oocyte or embryo vitrification","volume":"21","author":"Almog","year":"2010","journal-title":"Reprod. Biomed. Online"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2478\/raon-2021-0053","article-title":"In vitro maturation of immature oocytes for fertility preservation in cancer patients compared to control patients with fertility problems in an in vitro fertilization program","volume":"56","author":"Bedenk","year":"2021","journal-title":"Radiol. Oncol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.rbmo.2018.04.047","article-title":"Ovarian reserve and response to stimulation in women undergoing fertility preservation according to malignancy type","volume":"37","author":"Lefebvre","year":"2018","journal-title":"Reprod. Biomed. Online"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1007\/s10815-020-01944-x","article-title":"COH outcomes in breast cancer patients for fertility preservation: A comparison with the expected response by age","volume":"37","author":"Malacarne","year":"2020","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Faizal, A.M., Sugishita, Y., Suzuki-Takahashi, Y., Iwahata, H., Takae, S., Horage-Okutsu, Y., and Suzuki, N. (2022). Twenty-first century oocyte cryopreservation\u2014In vitro maturation of immature oocytes from ovarian tissue cryopreservation in cancer patients: A systematic review. Women\u2019s Health, 18.","DOI":"10.1177\/17455057221114269"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"De Roo, C., and Tilleman, K. (2021). In vitro maturation of oocytes retrieved from ovarian tissue: Outcomes from current approaches and future perspectives. J. Clin. Med., 10.","DOI":"10.3390\/jcm10204680"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"S420","DOI":"10.1016\/j.fertnstert.2008.07.1338","article-title":"Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation for fertility preservation","volume":"90","author":"Azem","year":"2008","journal-title":"Fertil. Steril."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"15261","DOI":"10.1038\/ncomms15261","article-title":"A bioprosthetic ovary created using 3D printed microporous scaffolds restores ovarian function in sterilized mice","volume":"8","author":"Laronda","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/13697137.2021.1921726","article-title":"Three-dimensional bioprinting of artificial ovaries by an extrusion-based method using gelatin-methacryloyl bioink","volume":"25","author":"Wu","year":"2022","journal-title":"Climacteric"}],"container-title":["Clinics and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2039-7283\/13\/6\/127\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:22:02Z","timestamp":1760131322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2039-7283\/13\/6\/127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,13]]},"references-count":111,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["clinpract13060127"],"URL":"https:\/\/doi.org\/10.3390\/clinpract13060127","relation":{},"ISSN":["2039-7283"],"issn-type":[{"value":"2039-7283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,13]]}}}